If you're a UK-based healthcare professional, you can register on Guidelines for free access to all of our content, including summaries and CPD modules.
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic
This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic
Summary of NICE guidance on the management of COVID-19 in children, young people, and adults in primary care settings
New advice has been issued by the MRHA and JCVI on the link between the COVID-19 AstraZeneca vaccine and thrombosis and thrombocytopenia
The new guidance, entitled Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain, was developed in partnership with the Royal College of Physicians.
The new NICE guideline contains updated recommendations for Caesarean birth and replaces NICE clinical guideline 132
New Office for Health Promotion will focus on prevention of poor health and improving health outcomes
Commissioned by Boehringer Ingelheim Limited
Content funded and provided by GSK
Commissioned by Viatris
Funded by Allergan plc
Funded by Mylan
Site powered by Webvision Cloud